We are live on ! Find out more
BGMS icon

Bio Green Med Solution

9 hedge funds and large institutions have $119K invested in Bio Green Med Solution in 2026 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more capital inflows, than outflows

Capital inflows: $102K | Capital outflows: $78.2K

0.81% more ownership

Funds ownership: 1.61% → 2.42% (+0.81%)

0% more funds holding

Funds holding: 9 → 9 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

Holders
9
Holders Change
–
Holders Change %
0%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

BGMS Hedge Fund Activity: Q1 2026 in Review

9 of the 8,244 institutional investors tracked by Wall St. Rank reported a position in Bio Green Med Solution (BGMS) for Q1 2026, worth a combined $119K — up 1.3% from $117K a quarter earlier.

Fund positioning in BGMS was balanced in Q1 2026: 3 funds opened new positions, 3 closed out, 4 added to existing stakes and 0 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $26K. The largest seller was Two Sigma Securities, exiting entirely with an estimated $41.4K sold.

  • 9 institutional investors held Bio Green Med Solution (BGMS) as of Q1 2026, unchanged from Q4 2025.
  • Funds reported $119K of Bio Green Med Solution stock for Q1 2026, up 1.3% quarter-over-quarter.
  • 3 funds opened new Bio Green Med Solution positions in Q1 2026 and 3 closed out, a net change of 0 holders.
  • The largest Bio Green Med Solution buyer in Q1 2026 was Renaissance Technologies, an estimated $26K added.
  • The largest Bio Green Med Solution seller in Q1 2026 was Two Sigma Securities, an estimated $41.4K sold.

Based on aggregated 13F filings for Q1 2026.